LifeVantage Co. (NASDAQ:LFVN – Get Rating)’s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.75 and traded as high as $4.50. LifeVantage shares last traded at $4.06, with a volume of 110,428 shares traded.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on LifeVantage in a research report on Thursday. They set a “strong-buy” rating for the company.
LifeVantage Stock Performance
The stock has a market cap of $58.37 million, a PE ratio of -76.00 and a beta of 1.09. The business has a 50-day moving average of $3.66 and a 200 day moving average of $3.76.
LifeVantage Increases Dividend
Institutional Trading of LifeVantage
Several hedge funds and other institutional investors have recently added to or reduced their stakes in LFVN. Renaissance Technologies LLC grew its holdings in shares of LifeVantage by 0.3% during the 2nd quarter. Renaissance Technologies LLC now owns 974,318 shares of the company’s stock worth $4,238,000 after purchasing an additional 3,300 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of LifeVantage by 4.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 271,614 shares of the company’s stock worth $1,293,000 after purchasing an additional 11,964 shares during the period. BlackRock Inc. grew its holdings in shares of LifeVantage by 10.5% during the 1st quarter. BlackRock Inc. now owns 249,547 shares of the company’s stock worth $1,188,000 after purchasing an additional 23,788 shares during the period. EP Wealth Advisors LLC purchased a new stake in shares of LifeVantage during the 1st quarter worth about $234,000. Finally, State Street Corp grew its holdings in shares of LifeVantage by 7.6% during the 1st quarter. State Street Corp now owns 46,191 shares of the company’s stock worth $220,000 after purchasing an additional 3,281 shares during the period. Hedge funds and other institutional investors own 29.69% of the company’s stock.
LifeVantage Company Profile
LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs.
- Get a free copy of the StockNews.com research report on LifeVantage (LFVN)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.